Enlivex Therapeutics Ltd.
1.15
0.01 (0.88%)
At close: Jan 15, 2025, 1:27 PM

Ratios (Annual)

Discover comprehensive ratio statement breakdowns that reveal insights into revenue, expenses, and beyond.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17 FY16 FY15 FY14 FY13 FY12
PE Ratio -1.73 -1.71 -11.57 -8.01 -7.15 -5.12 -1.24 -1.03 -3.58 -11.16 -79.77 -398.87
PS Ratio n/a n/a n/a 48.76 n/a n/a n/a n/a n/a n/a n/a n/a
PB Ratio 1.67 1.28 1.31 3.13 6.43 2.24 2.33 1.90 3.07 2.55 16.44 1.22K
P/FCF Ratio -2.11 -2.26 -5.82 -9.23 -10.03 -6 -1.16 -1.07 -4.14 -17.52 -105.35 -613.03
P/OCF Ratio -2.13 -3.03 -6.36 -10.09 -10.31 -6.87 -1.16 -1.07 -4.16 -17.77 -105.6 -613.03
OCF/S Ratio n/a n/a n/a -4.83 n/a n/a n/a n/a n/a n/a n/a n/a
Debt / Equity Ratio 0.03 0.09 0.01 0.01 0.01 n/a n/a n/a n/a n/a n/a n/a
Quick Ratio 5.57 7.74 20.91 15.86 2.50 9.09 7.87 5.46 8.11 14.42 43.35 1.93
Current Ratio 5.57 7.92 18.32 8.72 2.75 9.09 7.87 5.46 8.11 14.42 43.35 1.93
Asset Turnover n/a n/a n/a 0.06 n/a n/a n/a n/a n/a n/a n/a n/a
Interest Coverage -2.10K -4.9 -58.8 -1.63K -1.23K n/a n/a n/a n/a n/a -574 n/a
Return on Equity (ROE) -0.97 -0.75 -0.11 -0.39 -0.9 -0.44 -1.88 -1.84 -0.86 -0.23 -0.21 -3.05
Return on Assets (ROA) -0.79 -0.63 -0.1 -0.34 -0.58 -0.38 -1.64 -1.51 -0.75 -0.21 -0.2 -1.47
Return on Capital (ROIC) -0.96 -0.42 -0.21 -0.27 -0.74 -0.54 -1.88 -1.82 -0.86 -0.23 -0.21 -3.01
Dividend Yield n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Gross Profit Margin n/a n/a n/a 87.44% n/a n/a n/a n/a n/a n/a n/a n/a
Net Profit Margin n/a n/a n/a -608.83% n/a n/a n/a n/a n/a n/a n/a n/a
Pretax Profit Margin n/a n/a n/a -519.28% n/a n/a n/a n/a n/a n/a n/a n/a
Operating Profit Margin n/a n/a n/a -429.73% n/a n/a n/a n/a n/a n/a n/a n/a
FCF Margin n/a n/a n/a -528.15% n/a n/a n/a n/a n/a n/a n/a n/a
EBITDA Margin n/a n/a n/a -417.17% n/a n/a n/a n/a n/a n/a n/a n/a

Create Price Alert on ENLV

Your price alert will notify you when the stock price is above 1.15.

Add to Watchlist